$ETRA News
Last published 19h ago
- 19h agoETRAElectra Therapeutics, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 19h agoETRAElectra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio HighlightsGlobeNewswireIpsoprubart Advancing in Global Registrational Program as Potential First Treatment for sHLH Broadly; Enrollment Completion Expected in Second Half of 2027
- 1w agoETRAElectra Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference in LondonGlobeNewswireSOUTH SAN FRANCISCO, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, Inc. (NASDAQ:ETRA) a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the
- 3w agoETRAStar Therapeutics Announces $200 Million Private Financing to Advance Pipeline of Best-in-Disease TherapiesBusiness WireFinancing will support Star’s next phase of growth, including advancement of current preclinical programs into the clinic and continued pipeline expansion Financing follows Incyte’s July 2026 acquisition of Star
- 1mo agoETRAElectra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public OfferingGlobeNewswireSOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, Inc., a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment